• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

稳定表达萤火虫荧光素酶的Hepa1-6-FLuc细胞系保留了其原始特性,并具有良好的生物发光成像能力。

Hepa1-6-FLuc cell line with the stable expression of firefly luciferase retains its primary properties with promising bioluminescence imaging ability.

作者信息

Li Yasha, Liu Mengnan, Cui Jiejie, Yang Ke, Zhao Li, Gong Mengjia, Wang Yi, He Yun, He Tongchuan, Bi Yang

机构信息

Stem Cell Biology and Therapy Laboratory, Ministry of Education Key Laboratory of Child Development and Disorders, The Children's Hospital of Chongqing Medical University, Chongqing 400014, P.R. China.

Department of Pediatric Surgery, The Children's Hospital of Chongqing Medical University, Chongqing 400014, P.R. China.

出版信息

Oncol Lett. 2018 May;15(5):6203-6210. doi: 10.3892/ol.2018.8132. Epub 2018 Feb 27.

DOI:10.3892/ol.2018.8132
PMID:29616102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5876459/
Abstract

Reliable animal models are required for the study of the molecular mechanisms and effects of chemotherapeutic drugs in hepatocarcinoma. tracing techniques based on firefly luciferase (FLuc) may optimize the non-invasive monitoring of experimental animals. The present study established a murine Hepa1-6-FLuc cell line that stably expressed a retrovirus-delivered FLuc protein gene. The cell morphology, proliferation, migration and invasion ability of Hepa1-6-FLuc cells were the same as that of the Hepa1-6 cells, and thus is suitable to replace Hepa1-6 cells in the construction of hepatocarcinoma animal models. No differences in subcutaneous tumor mass and its pathomorphology from implanted Hepa1-6-FLuc cells were observed compared with Hepa1-6 control tumors. Bioluminescence imaging indicated that the Luc signal of the Hepa1-6-FLuc cells was consistently strengthened with increases in tumor mass; however, the Luc signal of Hepa1-6-AdFLuc became weaker and eventually disappeared during tumor development. Therefore, compared with the transient expression by adenovirus, stable expression of the FLuc gene in Hepa1-6 cells may better reflect cell proliferation and survival , and provide a reliable source for the establishment of hepatocarcinoma models.

摘要

肝癌化疗药物分子机制及效应研究需要可靠的动物模型。基于萤火虫荧光素酶(FLuc)的示踪技术可优化对实验动物的无创监测。本研究建立了稳定表达逆转录病毒传递的FLuc蛋白基因的小鼠Hepa1-6-FLuc细胞系。Hepa1-6-FLuc细胞的细胞形态、增殖、迁移和侵袭能力与Hepa1-6细胞相同,因此适合在肝癌动物模型构建中替代Hepa1-6细胞。与Hepa1-6对照肿瘤相比,未观察到植入Hepa1-6-FLuc细胞后皮下肿瘤块及其病理形态有差异。生物发光成像表明,Hepa1-6-FLuc细胞的Luc信号随肿瘤块增大而持续增强;然而,Hepa1-6-AdFLuc的Luc信号在肿瘤发展过程中变弱并最终消失。因此,与腺病毒的瞬时表达相比,FLuc基因在Hepa1-6细胞中的稳定表达可能更好地反映细胞增殖和存活情况,并为建立肝癌模型提供可靠来源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5581/5876459/e0803598b5ba/ol-15-05-6203-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5581/5876459/2e2879556d75/ol-15-05-6203-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5581/5876459/9c853bf560e5/ol-15-05-6203-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5581/5876459/eb4601805e2b/ol-15-05-6203-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5581/5876459/3bc45be4154c/ol-15-05-6203-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5581/5876459/e0803598b5ba/ol-15-05-6203-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5581/5876459/2e2879556d75/ol-15-05-6203-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5581/5876459/9c853bf560e5/ol-15-05-6203-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5581/5876459/eb4601805e2b/ol-15-05-6203-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5581/5876459/3bc45be4154c/ol-15-05-6203-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5581/5876459/e0803598b5ba/ol-15-05-6203-g04.jpg

相似文献

1
Hepa1-6-FLuc cell line with the stable expression of firefly luciferase retains its primary properties with promising bioluminescence imaging ability.稳定表达萤火虫荧光素酶的Hepa1-6-FLuc细胞系保留了其原始特性,并具有良好的生物发光成像能力。
Oncol Lett. 2018 May;15(5):6203-6210. doi: 10.3892/ol.2018.8132. Epub 2018 Feb 27.
2
Non-invasive In Vivo Tracking of Mammalian Cells Stably Expressing Firefly Luciferase.对稳定表达萤火虫荧光素酶的哺乳动物细胞进行非侵入性体内追踪。
Methods Mol Biol. 2022;2524:299-306. doi: 10.1007/978-1-0716-2453-1_23.
3
Real-time in vivo monitoring of viable stem cells implanted on biocompatible scaffolds.对植入生物相容性支架上的活干细胞进行实时体内监测。
Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1887-98. doi: 10.1007/s00259-008-0751-z. Epub 2008 Apr 25.
4
Id protein-firefly luciferase N-fragment & firefly luciferase C-fragment-MyoD proteinId蛋白-萤火虫荧光素酶N片段&萤火虫荧光素酶C片段-MyoD蛋白
5
Molecular Imaging of Tumor Progression and Angiogenesis by Dual Bioluminescence.通过双生物发光对肿瘤进展和血管生成进行分子成像
Methods Mol Biol. 2022;2524:457-469. doi: 10.1007/978-1-0716-2453-1_34.
6
Stable luciferase expression does not alter immunologic or in vivo growth properties of GL261 murine glioma cells.稳定的荧光素酶表达不会改变GL261小鼠胶质瘤细胞的免疫或体内生长特性。
J Transl Med. 2014 Dec 3;12:345. doi: 10.1186/s12967-014-0345-4.
7
Bioluminescence imaging after HSV amplicon vector delivery into brain.将单纯疱疹病毒扩增子载体导入大脑后的生物发光成像。
J Gene Med. 2006 Jul;8(7):804-13. doi: 10.1002/jgm.909.
8
Firefly luciferase and RLuc8 exhibit differential sensitivity to oxidative stress in apoptotic cells.萤火虫荧光素酶和 RLuc8 在凋亡细胞中对氧化应激表现出不同的敏感性。
PLoS One. 2011;6(5):e20073. doi: 10.1371/journal.pone.0020073. Epub 2011 May 13.
9
Gaussia luciferase for bioluminescence tumor monitoring in comparison with firefly luciferase.用于生物发光肿瘤监测的海肾荧光素酶与萤火虫荧光素酶的比较。
Mol Imaging. 2011 Oct;10(5):377-85. doi: 10.2310/7290.2010.00057. Epub 2011 Apr 26.
10
Detection of Brain Tumors and Systemic Metastases Using NanoLuc and Fluc for Dual Reporter Imaging.使用纳米荧光素酶和萤火虫荧光素酶进行双报告基因成像检测脑肿瘤和全身转移灶
Mol Imaging Biol. 2016 Feb;18(1):62-9. doi: 10.1007/s11307-015-0864-2.

引用本文的文献

1
Non-invasive In Vivo Tracking of Mammalian Cells Stably Expressing Firefly Luciferase.对稳定表达萤火虫荧光素酶的哺乳动物细胞进行非侵入性体内追踪。
Methods Mol Biol. 2022;2524:299-306. doi: 10.1007/978-1-0716-2453-1_23.

本文引用的文献

1
Molecular Imaging of Tumor Angiogenesis and Therapeutic Effects with Dual Bioluminescence.肿瘤血管生成及治疗效果的双生物发光分子成像
Curr Pharm Biotechnol. 2017;18(5):422-428. doi: 10.2174/1389201018666170523165053.
2
In vivo bioluminescence imaging reveals copper deficiency in a murine model of nonalcoholic fatty liver disease.体内生物发光成像揭示了非酒精性脂肪性肝病小鼠模型中的铜缺乏。
Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):14219-14224. doi: 10.1073/pnas.1613628113. Epub 2016 Nov 29.
3
Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region.
亚太地区肝细胞癌的流行病学
Gut Liver. 2016 May 23;10(3):332-9. doi: 10.5009/gnl15257.
4
All-trans retinoic acid inhibits proliferation, migration, invasion and induces differentiation of hepa1-6 cells through reversing EMT in vitro.全反式维甲酸通过体外逆转 EMT 抑制 hepa1-6 细胞的增殖、迁移、侵袭和诱导分化。
Int J Oncol. 2016 Jan;48(1):349-57. doi: 10.3892/ijo.2015.3235. Epub 2015 Nov 6.
5
Synergistic anti-tumor efficacy of doxorubicin and flavopiridol in an in vivo hepatocellular carcinoma model.阿霉素与黄酮哌啶醇在体内肝癌模型中的协同抗肿瘤疗效
J Cancer Res Clin Oncol. 2015 Nov;141(11):2037-45. doi: 10.1007/s00432-015-1990-6. Epub 2015 May 20.
6
Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma.肝细胞癌诊断、治疗及预防的当前趋势与最新进展
Asian Pac J Cancer Prev. 2015;16(9):3595-604. doi: 10.7314/apjcp.2015.16.9.3595.
7
The evolving epidemiology of hepatocellular carcinoma: a global perspective.肝细胞癌不断演变的流行病学:全球视角
Expert Rev Gastroenterol Hepatol. 2015 Jun;9(6):765-79. doi: 10.1586/17474124.2015.1028363. Epub 2015 Apr 1.
8
In vivo cell tracking with bioluminescence imaging.利用生物发光成像进行体内细胞追踪。
Nucl Med Mol Imaging. 2015 Mar;49(1):3-10. doi: 10.1007/s13139-014-0309-x. Epub 2014 Nov 26.
9
High level of CFTR expression is associated with tumor aggression and knockdown of CFTR suppresses proliferation of ovarian cancer in vitro and in vivo.高水平的囊性纤维化跨膜传导调节因子(CFTR)表达与肿瘤侵袭相关,而CFTR基因敲低可在体外和体内抑制卵巢癌的增殖。
Oncol Rep. 2015 May;33(5):2227-34. doi: 10.3892/or.2015.3829. Epub 2015 Mar 3.
10
Hepatocellular carcinoma in a large medical center of China over a 10-year period: evolving therapeutic option and improving survival.中国一家大型医疗中心10年间的肝细胞癌:不断演变的治疗选择与生存率的提高
Oncotarget. 2015 Feb 28;6(6):4440-50. doi: 10.18632/oncotarget.2913.